ResMed gets revenue lift from Brightree
By HME News Staff
Updated Wed October 26, 2016
SAN DIEGO - ResMed reported revenues of $465.4 million for the first quarter of fiscal year 2017, a 13% increase compared to the same period the previous year.
Excluding Brightree's contribution, revenues were $432.4 million, a 5% increase.
“We had a solid start to our fiscal year with 13% constant currency revenue growth led by our Brightree software offerings and global device sales,” said CEO Mick Farrell in a press release. “During the quarter, we drove consumer sleep awareness through a new U.S. media partnership, and sponsored a positive clinical study showing that non-invasive ventilation significantly reduces the risk of re-hospitalization and dear for COPD.”
ResMed announced last week that it is teaming up with “The Dr. Oz Show” to launch a campaign to foster better public understanding of sleep health.
The company reported a net income of $76.1 million for the first quarter, a 4% decrease compared to the same period the previous year.
For the Americas, ResMed reported revenues of $301 million, an 18% increase. Excluding Brightree's contribution, revenues were $267.9 million, a 5% increase.
Comments